Swisher EM - Search Results

1

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer.

Tewari KS, Burger RA, Enserro D, Norquist BM, Swisher EM, Brady MF, Bookman MA, Fleming GF, Huang H, Homesley HD, Fowler JM, Greer BE, Boente M, Liang SX, Ye C, Bais C, Randall LM, Chan JK, Ferriss JS, Coleman RL, Aghajanian C, Herzog TJ, DiSaia PJ, Copeland LJ, Mannel RS, Birrer MJ, Monk BJ. Tewari KS, et al. Among authors: swisher em. J Clin Oncol. 2019 Sep 10;37(26):2317-2328. doi: 10.1200/JCO.19.01009. Epub 2019 Jun 19. J Clin Oncol. 2019. PMID: 31216226 Free PMC article. Clinical Trial.

2

The expression of epidermal growth factor receptor, HER-2/Neu, p53, and Ki-67 antigen in uterine malignant mixed mesodermal tumors and adenosarcoma.

Swisher EM, Gown AM, Skelly M, Ek M, Tamimi HK, Cain JM, Greer BE, Muntz HG, Goff BA. Swisher EM, et al. Gynecol Oncol. 1996 Jan;60(1):81-8. doi: 10.1006/gyno.1996.0015. Gynecol Oncol. 1996. PMID: 8557233

3

Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis.

Paley PJ, Swisher EM, Garcia RL, Agoff SN, Greer BE, Peters KL, Goff BA. Paley PJ, et al. Among authors: swisher em. Gynecol Oncol. 2001 Feb;80(2):176-80. doi: 10.1006/gyno.2000.6071. Gynecol Oncol. 2001. PMID: 11161856

4

Evaluation of a region on chromosome 1p in ovarian serous carcinoma that is frequently deleted in uterine papillary serous carcinoma.

Herzog TJ, Kowalski LD, Liu H, Arlt M, Swisher E. Herzog TJ, et al. Gynecol Oncol. 2001 Jul;82(1):139-42. doi: 10.1006/gyno.2001.6230. Gynecol Oncol. 2001. PMID: 11426975

5

Use of complementary and alternative medicine among women with gynecologic cancers.

Swisher EM, Cohn DE, Goff BA, Parham J, Herzog TJ, Rader JS, Mutch DG. Swisher EM, et al. Gynecol Oncol. 2002 Mar;84(3):363-7. doi: 10.1006/gyno.2001.6515. Gynecol Oncol. 2002. PMID: 11855870

6

Pathologic findings in prophylactic oophorectomy specimens in high-risk women.

Leeper K, Garcia R, Swisher E, Goff B, Greer B, Paley P. Leeper K, et al. Gynecol Oncol. 2002 Oct;87(1):52-6. doi: 10.1006/gyno.2002.6779. Gynecol Oncol. 2002. PMID: 12468342

7

The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer.

Everett E, Tamimi H, Greer B, Swisher E, Paley P, Mandel L, Goff B. Everett E, et al. Gynecol Oncol. 2003 Jul;90(1):150-7. doi: 10.1016/s0090-8258(03)00232-4. Gynecol Oncol. 2003. PMID: 12821356

8

Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancer.

Shah C, Johnson EB, Everett E, Tamimi H, Greer B, Swisher E, Goff B. Shah C, et al. Gynecol Oncol. 2005 Dec;99(3):564-70. doi: 10.1016/j.ygyno.2005.06.011. Epub 2005 Oct 24. Gynecol Oncol. 2005. PMID: 16246402

9

Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase I trial of the Puget Sound Oncology Consortium.

Puget Sound Oncology Consortium; Swisher EM, Swensen RE, Greer B, Tamimi H, Goff BA, Garcia R, Koh WJ. Puget Sound Oncology Consortium, et al. Among authors: swisher em. Gynecol Oncol. 2006 Jun;101(3):429-35. doi: 10.1016/j.ygyno.2005.10.032. Epub 2005 Dec 9. Gynecol Oncol. 2006. PMID: 16337995 Clinical Trial.

10

The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer.

Lachance JA, Everett EN, Greer B, Mandel L, Swisher E, Tamimi H, Goff B. Lachance JA, et al. Gynecol Oncol. 2006 Jun;101(3):470-5. doi: 10.1016/j.ygyno.2005.11.009. Epub 2006 Jan 18. Gynecol Oncol. 2006. PMID: 16413048

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters